首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current breast cancer reports

缩写:

ISSN:1943-4588

e-ISSN:1943-4596

IF/分区:1.0/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引98
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mary Playdon,Gwendolyn Thomas,Tara Sanft et al. Mary Playdon et al.
To determine the effectiveness of weight loss intervention for breast cancer survivors. From October 2012 until March 2013, Pubmed was searched for weight loss intervention trials that reported body weight or weight loss as a primary outcom...
Ad A Kaptein,Jan W Schoones,Maarten J Fischer et al. Ad A Kaptein et al.
Women with breast cancer respond to the illness and its medical management in their own personal way. Their coping behavior and self-management are determined by their views (cognitions) and feelings (emotions) about symptoms and illness: t...
Jane M Armer,Jennifer M Hulett,Michael Bernas et al. Jane M Armer et al.
Breast cancer-related lymphedema (LE) is a progressive, chronic disease that affects millions of cancer survivors and primarily results from surgical lymphatic vessel/node removal and radiation therapy. Patient education and support for imp...
Sasmit Sarangi,Kailash Mosulpuria,Michaela J Higgins et al. Sasmit Sarangi et al.
Circulating Tumor cells (CTCs) represent tumor cells in the blood stream dislodged from the primary tumor. The presence of CTCs in the bloodstream provides a unique opportunity to sample cancer tissue by means of a relatively less-invasive ...
Vandana G Abramson,Ingrid A Mayer Vandana G Abramson
Triple-negative breast cancers (TNBCs) are known to be an aggressive group of breast cancers with higher rates of relapse stage for stage compared to ER/PR positive and HER2 positive breast cancers despite optimal loco-regional and systemic...
Ciara C O&#x;Sullivan,Karen L Smith Ciara C O&#x;Sullivan
Despite advances in detection and treatment, metastatic breast cancer (MBC) remains the second highest cause of cancer-related death for women in the United States. Human epidermal growth factor receptor-2 (HER2) is amplified in 25-30% of b...
Terisse Brocato,Prashant Dogra,Eugene J Koay et al. Terisse Brocato et al.
Chemotherapy is mainstay of treatment for the majority of patients with breast cancer, but results in only 26% of patients with distant metastasis living 5 years past treatment in the United States, largely due to drug resistance. The compl...
Elgene Lim,Min Ni,Shiliang Cao et al. Elgene Lim et al.
The androgen receptor (AR) has re-emerged as a potential therapeutic target in breast cancer. This stems from recent progress made in preclinical models, that have recognized important differences in the effect of AR expression on patient o...
Beate C Litzenburger,Powel H Brown Beate C Litzenburger
Preventing breast cancer is an effective strategy for reducing breast cancer deaths. The purpose of chemoprevention (also termed preventive therapy) is to reduce cancer incidence by use of natural, synthetic, or biological agents. The effic...
Giuliano Bedoschi,Volkan Turan,Kutluk Oktay Giuliano Bedoschi
Breast cancer is the most common type of malignancy in reproductive-age women. Breast cancer chemotherapy is associated with premature ovarian failure, infertility and negative psychosocial effects related to these reproductive changes. As ...